Skip to main content
Advanced Biomed Inc. logo

Advanced Biomed Inc. — Investor Relations & Filings

Ticker · ADVB ISIN · US00752P1049 US Professional, scientific and technical activities
Open in API
Filings indexed 85 across all filing types
Latest filing 2023-11-20 Regulatory Filings
Country US United States of America
Listing US ADVB

About Advanced Biomed Inc.

http://www.advanbiomed.com/

Advanced Biomed Inc. is a company specializing in the research, development, and commercialization of advanced diagnostic systems for precision oncology. The company focuses on developing proprietary microfluidic biochip technologies that integrate semiconductor and biotechnology principles. Its platform provides assay products and services that cover the full spectrum of cancer care, including early screening, detection, diagnosis, staging, and treatment selection. A key technology involves diagnostic devices that capture circulating tumor cells through physical trapping, offering an alternative to traditional antibody-based methods. The company aims to provide rapid and affordable solutions to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2023
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC Division of Corporate Finance responding to comments on an Amendment No. 5 to a Registration Statement on Form S-1. It discusses specific SEC staff comments and the company's responses regarding disclosures in the registration statement, including management's discussion and analysis, liquidity and capital resources, and industry-academia cooperation agreements. The document is a correspondence related to a registration statement amendment, not a financial report or earnings release. It is a regulatory filing responding to SEC comments, which fits the Regulatory Filings (RNS) category as it does not contain financial statements or detailed financial data itself but is part of the regulatory review process.
2023-11-20 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is related to the registration of securities for an initial public offering (IPO) by Advanced Biomed Inc. The text includes detailed disclosures about the company, its subsidiaries, regulatory risks, and the offering details. This type of filing is specifically used for registering securities for public sale and is not a financial report, earnings release, or other types of filings listed. The Form S-1/A is a registration statement amendment, which falls under the category of Capital/Financing Update as it pertains to fundraising activities and securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a mere announcement but the actual registration statement amendment filing.
2023-11-20 English
Regulatory Filings 2023
Regulatory Filings
2023-11-06 English
Regulatory Filings 2023
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC staff responding to comments on an Amendment No. 4 to a Registration Statement on Form S-1, with references to Amendment No. 5. It discusses updates to financial statements, market data citations, and director jurisdictions. The document is a correspondence related to regulatory review and amendments to a registration statement, not the registration statement itself or a financial report. The length is 3120 characters, which is relatively short and consistent with a regulatory correspondence letter. This fits the category of Regulatory Filings (RNS), which includes correspondence and compliance documents submitted to regulators that do not fit other specific categories.
2023-10-27 English
FORM S-1A
Regulatory Filings Classification · 100% confidence The document is a Form S-1/A (Amendment No. 5) registration statement filed with the SEC on October 27, 2023. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of common stock by Advanced Biomed Inc. The text includes detailed disclosures about the company, its subsidiaries, regulatory risks, and the offering details. Form S-1 is a registration statement used for securities offerings, not a financial report or earnings release. It is not an announcement of a report but the actual registration filing document. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory filing that does not fit into other specific categories like Annual Report or Earnings Release.
2023-10-27 English
Regulatory Filings 2023
Regulatory Filings
2023-09-08 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.